Clinical Practice Guideline

Diagnosis and Treatment of Hyperprolactinemia

February 01, 2011

Full Guideline: Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
JCEM February 2011
Shlomo Melmed, Felipe F. Casanueva, Andrew R. Hoffman, David L. Kleinberg, Victor M. Montori, Janet A. Schlechte, John A. H. Wass

Objective:

The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia.

Introduction:

Testing for hyperprolactinemia is straightforward, owing to the ease of ordering a serum prolactin measurement. Accordingly, an evidence-based, cost-effective approach to management of this relatively common endocrine disorder is required.

Conclusions:

  • Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels.
  • These include:
    • evidence-based approaches to assessing the cause of hyperprolactinemia
    • treating drug-induced hyperprolactinemia
    • and managing prolactinomas in nonpregnant and pregnant subjects
  • Indications and side effects of therapeutic agents for treating prolactinomas are also presented

arrow Read the Full Guideline

Clinical Practice Guideline Mobile App
Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Clinical Practice Guideline Mobile App

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Newly Designed CPG Mobile App
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.